1Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China
2Tianjin’s Clinical Research Center for Cancer, Tianjin, China
3Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
4Department of Oncology, Peking University International Hospital, Beijing, China
5Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Oncology, Peking University Cancer Hospital and Institute, Beijing, China
6Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China
7Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
8Beijing Chao-Yang Hospital, Beijing, China
9Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
